nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2004-8-4-41-44nefr-880Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПОЛНАЯ АПЛАЗИЯ КРАСНОГО КОСТНОГО МОЗГА В РЕЗУЛЬТАТЕ ЛЕЧЕНИЯ ЭРИТРОПОЭТИНОМTOTAL APLASIA OF THE RED BONE MARROW AS A RESULT OF TREATMENT WITH ERYTHROPOIETINОрловаЕ. А.OrlovaE. A.

Кафедра терапии и профзаболеваний им. Е.М. Тареева

ЛашутинС. В.LashutinS. V.

Кафедра терапии и профзаболеваний им. Е.М. Тареева

Московская медицинская академия им. И.М. СеченоваRussian Federation200410042004844144Copyright © Орлова Е.А., Лашутин С.В., 20042004Орлова Е.А., Лашутин С.В.Orlova E.A., Lashutin S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/880

Полная аплазия красного костного мозга в результате лечения эритропоэтином.

Total aplasia of the red bone marrow as a result of treatment with erythropoietin.

рекомбинантный человеческий эритропоэтинполная аплазия красного костного мозгаrecombinant human erythropoietinpure red cell aplasiaReferencesEckardt KU, Casadevall N. Pure redcell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003 18: 865869Eckardt KU, Casadevall N. Pure redcell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003 18: 865869Casadevall N, Nataf J, Viron B et al. Pure redcell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469–475Casadevall N, Nataf J, Viron B et al. Pure redcell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469–475Casadevall N, Dupuy E, MolhoSabatier P et al. Autoantibodies against erythropoietin in a patient with pure redcell aplasia. N Engl J Med 1996; 334: 630–633Casadevall N, Dupuy E, MolhoSabatier P et al. Autoantibodies against erythropoietin in a patient with pure redcell aplasia. N Engl J Med 1996; 334: 630–633Casadevall N. Antibodies against rHuEpo: native and recombinant. Nephrol Dial Transplant 2002; 17 [Suppl 5]: 42–47Casadevall N. Antibodies against rHuEpo: native and recombinant. Nephrol Dial Transplant 2002; 17 [Suppl 5]: 42–47Locatelli F, Del Vecchio L. Pure red cell aplasia secondary to treatment with erythropoietin. Artificial Organs 2003; 27(9):755–758Locatelli F, Del Vecchio L. Pure red cell aplasia secondary to treatment with erythropoietin. Artificial Organs 2003; 27(9):755–758Locatelli F, Aljama P, Barany P et al. Erythropoiesis stimulating agents and antibodymediated pure redcell aplasia: where are we now and where do we go from here? Nephrol Dial Transplant 2004 19: 288293Locatelli F, Aljama P, Barany P et al. Erythropoiesis stimulating agents and antibodymediated pure redcell aplasia: where are we now and where do we go from here? Nephrol Dial Transplant 2004 19: 288293

The authors declare that there are no conflicts of interest present.